TradeUP Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch UPTD and buy or sell other stocks, ETFs, and their options commission-free!About UPTD
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
CEOCheng Liu, PhD
CEOCheng Liu, PhD
Employees—
Employees—
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded
Founded
Employees—
Employees—
UPTD Key Statistics
Market cap43.81M
Market cap43.81M
Price-Earnings ratio-4.16
Price-Earnings ratio-4.16
Dividend yield—
Dividend yield—
Average volume95.83K
Average volume95.83K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.15
52 Week high$3.15
52 Week low$0.7301
52 Week low$0.7301
Stock Snapshot
TradeUP Acquisition(UPTD) stock is priced at $1.16, giving the company a market capitalization of 43.81M. It carries a P/E multiple of -4.16.
TradeUP Acquisition(UPTD) stock opened on 2025-12-28 at —. The price climbed to — and dipped to —.
TradeUP Acquisition(UPTD) shares are trading with a volume of 0, against a daily average of 95.83K.
In the last year, TradeUP Acquisition(UPTD) shares hit a 52-week high of $3.15 and a 52-week low of $0.73.
In the last year, TradeUP Acquisition(UPTD) shares hit a 52-week high of $3.15 and a 52-week low of $0.73.
People also own
Based on the portfolios of people who own UPTD. This list is generated using Robinhood data, and it’s not a recommendation.